Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesGeneral SurgeryCurative Splenectomy Coverage Update | OpenPayer
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ModifiedCurativePolicy CHP-IP-2026-148

    Acute Inpatient Splenectomy

    Customize your policy alerts

    Sign up for curative Policy CHP-IP-2026-148 alerts

    Get alerted when Policy CHP-IP-2026-148 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity and acute inpatient level-of-care coverage for open or laparoscopic total or partial splenectomy for trauma, hematologic disease, abscess or infarction, and splenic neoplasm. It applies to all ages, with pediatric trauma and elective pediatric considerations noted in the policy.

    Policy Summary
    PayerCurative
    PolicyAcute Inpatient Splenectomy
    Policy CodePolicy CHP-IP-2026-148
    Change TypeModified
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument at least one qualifying splenectomy indication and why inpatient care is required.
    SourceLink
    POLICY UPDATE CHANGES

    Version 5.4.2 supersedes version 5.4.1 and is identified as unchanged between versions.

    ICD-10-CM and ICD-10-PCS codes were verified against the FY2027 CMS code files, and invalid, header-only, or mislabeled codes were corrected.

    1-3 daysElective laparoscopic length of stay
    3-5 daysOpen-procedure length of stay
    NEWS2 ≥7ICU escalation threshold
    14 daysEmergency vaccination timing
    3 monthsMinimum ITP treatment duration

    Medical Necessity and Level-of-Care Criteria

    Acute inpatient admission

    Acute inpatient splenectomy is medically necessary when ALL of the following are met.

    Inpatient splenectomy

    • Procedure indications

      • Trauma: Splenic injury with systolic blood pressure below 90 mmHg, ongoing transfusion or vasopressor requirement, peritonitis, or failed nonoperative management or angioembolization.SBP <90 mmHg or ongoing transfusion/vasopressors
      • Immune thrombocytopenia: ITP lasting at least 3 months, corticosteroid-dependent or unresponsive, with failure, intolerance, or contraindication to at least one second-line agent.At least 3 months; preferably at least 12 months after diagnosis
    Policy Summary
    PayerCurative
    PolicyAcute Inpatient Splenectomy
    Policy CodePolicy CHP-IP-2026-148
    Change TypeModified
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument at least one qualifying splenectomy indication and why inpatient care is required.
    SourceLink
    On This Page
    Medical Necessity and Level-of-Care CriteriaCoding and Clinical ThresholdsAuthorization and Documentation RequirementsClinical ContextKey Definitions

    A second-line agent is a thrombopoietin receptor agonist or rituximab.

  1. Hereditary hemolytic anemia: Hereditary spherocytosis or another hereditary hemolytic anemia with transfusion dependence, symptomatic anemia, growth impairment, or symptomatic gallstones per hematology recommendation.
  2. Hypersplenism: Transfusion-dependent or symptomatic cytopenias, or symptomatic splenomegaly, not controlled by treatment of the underlying disease.
  3. Other splenic disease: Splenic abscess not amenable to or failing percutaneous drainage; symptomatic or complicated splenic infarction; or splenic cyst or mass requiring diagnosis or resection.
  4. Inpatient setting required

    • Postoperative monitoring: Any splenectomy requires inpatient postoperative monitoring for bleeding, pancreatic tail injury, and platelet response.
    • Procedure or anatomy complexity: Massive splenomegaly or an open approach.Spleen longer than 20 cm
    • Higher-risk patient: ASA physical status III or higher, or documented frailty, with anticipated postoperative physiologic monitoring beyond observation capability.ASA III or higher
    • Significant comorbidity: Heart failure with LVEF 40% or less or NYHA III-IV symptoms; insulin-treated diabetes requiring IV insulin or frequent titration; obstructive sleep apnea with parenteral opioid requirement and continuous oximetry; CKD stage 4-5 or dialysis; or therapeutic anticoagulation requiring bridging.LVEF ≤40%; NYHA III-IV; CKD stage 4-5
    • Intraoperative event: Blood loss requiring transfusion, conversion to open approach, unplanned additional organ resection, or difficult airway changes the expected course.
  5. Observation or outpatient instead of inpatient

    Observation or outpatient care rather than inpatient splenectomy is appropriate when ANY of the following applies.

    Lower level of care: The patient has a hemodynamically stable splenic injury managed nonoperatively with serial examinations and hemoglobin monitoring, or is receiving pre-splenectomy vaccination and hematologic optimization as outpatient services.

    Nonoperative injury management and angioembolization admissions are addressed under trauma policies.

    Intensive care unit

    ICU care is appropriate when ANY of the following is documented.

    ICU level of care: Traumatic splenic injury with shock or polytrauma requiring damage-control surgery; vasopressor or inotrope infusion to maintain MAP ≥65 mmHg or septic shock; invasive mechanical ventilation or escalating noninvasive support for acute respiratory failure; active hemorrhage with instability or massive transfusion protocol activation pending further intervention; or persistent NEWS2 ≥7 after initial treatment with documented need for organ support or continuous one-to-one monitoring.MAP ≥65 mmHg with vasopressors; septic lactate >2 mmol/L; SpO2 <90% despite FiO2 ≥0.6; pH <7.25 with rising PaCO2; NEWS2 ≥7

    Step-down or intermediate care

    Step-down or intermediate care is appropriate when ANY of the following is documented and no ICU criterion is present.

    Intermediate level of care: Platelet count below 20,000 per microliter after splenectomy for ITP with ongoing bleeding risk; NEWS2 5-6 or a single-parameter score of 3 requiring vital signs at least every 1-2 hours without organ support; new hemodynamically significant arrhythmia requiring continuous monitoring and rate-control titration; or a stable patient requiring noninvasive ventilation or high-flow oxygen, or with obstructive sleep apnea and parenteral opioids requiring continuous pulse oximetry and capnography.Platelets <20,000/µL; NEWS2 5-6 or single-parameter score 3

    Medical-surgical unit

    Medical-surgical unit care is appropriate when ANY of the following applies.

    Medical-surgical level of care: Postoperative care requires diet advancement, drain monitoring, and platelet or hemoglobin trending; the patient is hemodynamically stable with ongoing hospital-level services such as parenteral or epidural analgesia, IV fluids or antibiotics, drain or wound management, or monitored diet advancement; or vital signs every 4 hours are adequate with no ICU or step-down criterion.NEWS2 0-4

    Discharge readiness

    Discharge from acute care is appropriate when ALL of the following are met.

    • Clinical stability: Temperature is below 38.0 C for at least 24 hours or a fever source has an oral/outpatient plan; vital signs are stable with NEWS2 0-4 on room air or baseline home oxygen for 12-24 hours; pain is controlled on oral analgesics with an opioid-sparing regimen; and oral intake is tolerated or a nutrition plan is arranged.Temperature <38.0 C; NEWS2 0-4 for 12-24 hours
    • Laboratory and functional stability: Hemoglobin is stable without transfusion for at least 24 hours, creatinine and electrolytes are at or near baseline or have a follow-up plan, and mobility is at the expected post-procedure level or safe transfer to post-acute care is arranged.No transfusion for at least 24 hours
    • Safe transition: Medication reconciliation, venous thromboembolism prophylaxis plan, wound and drain instructions, return precautions, and follow-up appointment are documented.
    • Asplenia prevention and platelet plan: Pneumococcal, MenACWY, MenB, and Hib vaccination is completed or scheduled; a fever action plan and antibiotic guidance are provided; and platelet count is stable or rising with a thromboprophylaxis decision documented for reactive thrombocytosis or portal vein thrombosis risk.Vaccination at least 14 days after emergency splenectomy if not given earlier

    Continued-stay criteria

    Continued acute inpatient stay is medically necessary when ANY of the following is documented at each review.

    Continued stay: Any ICU or step-down criterion is present or NEWS2 is ≥5; IV therapy cannot be provided at a lower level; oral intake is not tolerated or ileus requires nasogastric decompression; an urgent procedure, imaging study, or consultation expected within 24 hours may change acute management; post-splenectomy hemorrhage, subphrenic abscess, or pancreatic tail leak requires drainage, IV antibiotics, or reoperation; portal or splenic vein thrombosis requires anticoagulation initiation and monitoring; or associated traumatic injuries require continued acute care.NEWS2 ≥5

    Does not meet criteria

    The following scenarios do not meet medical-necessity criteria and are referred for physician review.

    Does not meet criteria: Stable blunt splenic injury without failed nonoperative management or another operative indication; ITP within 12 months without failure of corticosteroids and at least one second-line agent; staging splenectomy for lymphoma; preoperative admission more than one day before surgery for scheduling, travel, or convenience; continued stay after discharge readiness without an acute need; or custodial, respite, or convenience days.

    The request is not denied by an automated system or non-physician reviewer. An adverse determination requires physician review and an opportunity for peer-to-peer discussion.

    Splenic trauma

    Operative management for splenic trauma is supported when either clinical instability or failure of nonoperative management is present.

    Operative indication in splenic trauma

    • Hemodynamic instability: The patient is hemodynamically unstable.
    • Failed nonoperative management: Nonoperative management has failed.

    Immune thrombocytopenia

    For ITP, splenectomy is considered after the specified treatment history, with treatment sequencing and delay considerations.

    ITP treatment sequencing: The patient has corticosteroid-dependent or corticosteroid-unresponsive immune thrombocytopenia after at least 3 months of treatment, and splenectomy is being considered among subsequent treatment options.At least 3 months; preferably at least 12 months after diagnosis

    The required second-line treatment history includes failure, intolerance, or contraindication to at least one thrombopoietin receptor agonist or rituximab. Rituximab is preferred to splenectomy when appropriate, and splenectomy should be delayed for at least 1 year when possible.

    Staging splenectomy for lymphoma is excluded as not medically necessary because PET-CT staging has replaced surgical staging.

    Custodial, respite, or convenience days do not meet acute inpatient coverage criteria and are excluded from acute-level coverage.

    Splenectomy for a hemodynamically stable blunt splenic injury is not medically necessary when nonoperative management has not failed and no other operative indication is present. Nonoperative management, with or without angioembolization, is recommended; such requests are referred for physician review.

    Staging splenectomy for lymphoma is not medically necessary because PET-CT staging has replaced surgical staging.

    A preoperative admission more than one day before surgery for scheduling, travel, or convenience is not medically necessary. Preoperative evaluation and preparation can be completed as an outpatient.

    A continued inpatient stay after discharge-readiness criteria are met is not medically necessary when there is no acute need, including days awaiting post-acute placement, transportation, or equipment.

    Custodial, respite, or convenience days are not medically necessary at the acute inpatient level.

    Coding and Clinical Thresholds

    ICD-10-CM: splenic disordersICD-10
    D73.1Chronic congestive splenomegaly
    D73.3Abscess of spleen
    D73.5Infarction of spleen
    D73.89Other diseases of spleen
    ICD-10-CM: hematologic indicationsICD-10
    D69.3Immune thrombocytopenic purpura
    D58.0Hereditary spherocytosis
    D58.1Other hereditary hemolytic anemias
    ICD-10-CM: splenic neoplasmICD-10
    C96.4Blastic plasmacytoid dendritic cell neoplasm
    ICD-10-CM: splenic injuryICD-10
    S36.020AMajor laceration of spleen, initial encounter
    S36.021AMinor laceration of spleen, initial encounter
    S36.030AMajor contusion of spleen, initial encounter
    S36.031AMinor contusion of spleen, initial encounter
    S36.032AOther injury of spleen, initial encounter
    S36.09XAOther injury of spleen, initial encounter
    ICD-10-PCS: spleen resectionICD-10
    07TP0ZZResection of spleen, open approach
    07TP4ZZResection of spleen, percutaneous endoscopic approach
    CPT: splenectomyCPT
    38100Splenectomy; total (separate procedure)
    38101Splenectomy; partial
    38102Splenectomy; total or partial, laparoscopic
    38120Laparoscopic surgical splenectomy
    MS-DRG (FY2027 v44)Revenue
    799Splenic procedures with MCC
    800Splenic procedures with CC
    801Splenic procedures without CC/MCC
    957Other O.R. procedures for multiple significant trauma with MCC
    958Other O.R. procedures for multiple significant trauma with CC
    959Other O.R. procedures for multiple significant trauma without CC/MCC
    Revenue codes (facility)Revenue
    0120Room and board - semi-private two bed
    0121Room and board - semi-private one bed
    0200Intensive care unit
    0206Intermediate ICU
    0360Operating room services
    0370Anesthesia
    0710Clinic
    0762Treatment or observation room
    Splenic injury hemodynamic instability
    Systolic blood pressureBelow 90 mmHg
    TransfusionOngoing transfusion requirement
    VasopressorsOngoing vasopressor requirement
    Massive splenomegaly
    Spleen lengthLonger than 20 cm
    Clinical findingMassive splenomegaly
    Inpatient relevanceSupports an inpatient setting requirement for splenectomy
    ITP duration
    Minimum durationAt least 3 months
    Preferred timingPreferably at least 12 months after diagnosis before splenectomy
    Treatment contextCorticosteroid-dependent or corticosteroid-unresponsive ITP with required second-line treatment history
    Septic shock
    Vasopressor criterionVasopressor requirement
    Lactate criterionLactate above 2 mmol/L
    Fluid statusCriteria apply despite adequate fluid resuscitation
    Acute respiratory failure escalation
    OxygenationSpO2 below 90% despite FiO2 of 0.6 or higher
    Acid-basepH below 7.25
    Ventilatory trendRising PaCO2 with the acid-base criterion
    Post-splenectomy thrombocytopenia
    Platelet countBelow 20,000 per microliter
    Bleeding riskOngoing bleeding risk requiring frequent monitoring
    Care levelStep-down or intermediate care is appropriate when no ICU criterion is present
    Discharge fever criterion
    TemperatureBelow 38.0 C
    DurationFor at least 24 hours
    AlternativeAn identified fever source with an oral or outpatient treatment plan
    Concurrent review interval
    ICU or step-downConcurrent review at least daily
    Medical-surgical unitConcurrent review at least every 48 hours
    Additional review triggerReview is also triggered by any red flag or when the expected-length-of-stay benchmark is reached

    Authorization and Documentation Requirements

    Documentation Required

    Inpatient Splenectomy Medical Necessity

    Submit documentation showing at least one qualifying indication for splenectomy and why acute inpatient postoperative care is required. Qualifying indications include unstable or complicated splenic injury, appropriately treated ITP, hereditary hemolytic anemia with qualifying symptoms or transfusion dependence, uncontrolled hypersplenism, or a complicated abscess, infarction, cyst, or mass.

    • Document the specific procedure indication and supporting clinical findings.
    • Document the inpatient need, including postoperative monitoring needs, massive splenomegaly or open approach, or ASA III-or-higher status/frailty requiring monitoring beyond observation.
    Step Therapy

    ITP Second-Line Treatment Required

    For ITP, document disease duration, corticosteroid dependence or lack of response, and failure, intolerance, or contraindication to at least one second-line agent before requesting splenectomy.

    • Document ITP duration of at least 3 months and, preferably, at least 12 months from diagnosis.
    • Identify the second-line treatment used or considered, such as a thrombopoietin receptor agonist or rituximab, and provide the response, failure, intolerance, or contraindication.
    Documentation Required

    Procedure Plan and Indication

    Submit the operative or procedure plan with the specific indication, staging or classification, and planned approach.

    • Identify whether the approach is open, laparoscopic, or robotic.
    Documentation Required

    Risk Assessment

    Document the patient's ASA physical status, relevant comorbidities, and anesthesia risk assessment.

    • Explain any anticipated need for postoperative physiologic monitoring beyond observation.
    Documentation Required

    Operative Details

    Provide the operative note with the clinical details needed to evaluate the procedure and postoperative risk.

    • Estimated blood loss and transfusions
    • Intraoperative events
    • Drains or devices placed
    Documentation Required

    Concurrent-Stay Documentation

    For each continued-stay period, document current clinical data and the specific reason acute inpatient care remains necessary.

    • Include vital signs or NEWS2, intake and output, drain output, and laboratory trends.
    • Concurrent review applies to each continued-stay period; days already authorized are not retroactively denied.
    Documentation Required

    Level-of-Care Support

    When ICU or step-down care is used, document the assigned level of care and the objective clinical finding supporting that placement.

    • Tie the requested level of care to the patient's documented physiologic monitoring or treatment needs.
    Documentation Required

    Discharge Planning

    Document discharge readiness and the transition plan when acute inpatient care is no longer required.

    • Include post-acute referral when applicable.
    • Address the plan for transition rather than using continued acute care for placement, transportation, or equipment delays.
    Documentation Required

    Trauma Documentation

    For trauma cases, provide the objective injury and treatment history supporting operative management or continued acute care.

    • Hemodynamic status, including instability, ongoing transfusion, or vasopressor need
    • CT grade of splenic injury
    • Course of nonoperative management and any angioembolization, including failure when applicable
    Documentation Required

    ITP Treatment History

    For ITP requests, provide a complete treatment history and current disease status.

    • Duration of ITP
    • Treatments tried, with dates and responses
    • Current platelet count
    Documentation Required

    Vaccination Documentation

    Provide vaccination documentation relevant to splenectomy and show the timing of each vaccination relative to surgery.

    • Include the vaccination record and administration dates.
    Billing Rule

    Documentation Must Support Requested Scope

    The documentation must support the full requested scope. If the record supports only part of the requested quantity, units, or duration, the supported portion may be approved and only the unsupported increment reviewed.

    • Ensure the requested quantity, units, and duration are consistent with the clinical documentation.

    Unsupported block type: denial_risk

    Unsupported block type: denial_risk

    Unsupported block type: denial_risk

    Unsupported block type: denial_risk

    Unsupported block type: denial_risk

    Unsupported block type: denial_risk

    Prior Authorization

    Adverse Determination and Peer-to-Peer Review

    Automated systems and non-physician clinical reviewers may approve a request in full or in part but may not issue an adverse determination. An adverse determination requires physician review after offering the requesting provider a peer-to-peer discussion with a physician of the same or similar specialty.

    • The reviewing physician must meet applicable licensure, specialty, and medical-director requirements for the plan's situs state.
    • The absence of a criterion addressing a service is not by itself a basis for an adverse determination; the physician applies generally accepted standards of medical practice.

    Clinical Context

    Most hemodynamically stable blunt splenic injuries are managed nonoperatively, with angioembolization used for contrast blush or other high-risk findings. Splenectomy is generally reserved for hemodynamic instability, failed nonoperative management, or associated injuries requiring laparotomy.

    Key Definitions

    Clinical severity findings
    Examination findingsObjective, documented examination findings that establish acuity
    Physiologic findingsVital-sign or laboratory findings that establish acuity
    Diagnostic findingsImaging or validated-score findings that establish acuity
    Hospital-level services required
    DefinitionServices that cannot be delivered safely in observation, ambulatory, home, or post-acute settings
    Intravenous therapyFrequent titration of intravenous therapy
    Monitoring and proceduresContinuous monitoring or procedures with significant early complication risk
    Expected length of stay
    DefinitionA planning benchmark for an uncomplicated course based on the CMS FY2027 MS-DRG geometric mean length of stay
    Laparoscopic elective course1-3 days
    Open-procedure course3-5 days
    Coverage effectThe benchmark is not a limit on covered days
    NEWS2
    Full nameNational Early Warning Score 2
    Physiologic componentsRespiratory rate, oxygen saturation, supplemental oxygen, systolic blood pressure, heart rate, level of consciousness, and temperature
    Urgent reviewA score of 5-6 or a single parameter score of 3 prompts urgent review
    Emergency responseA score of 7 or more prompts emergency response
    ASA physical status
    Full nameAmerican Society of Anesthesiologists preoperative comorbidity classification
    Class IIISevere systemic disease
    Class IVSevere systemic disease that is a constant threat to life